UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 246

Sortiert nach

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

PloS one, 2009-07, Vol.4 (7), p.e6146-e6146

2009

Link zum Volltext

Verfügbarkeit prüfen

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (41), p.14788-14793

2014

Link zum Volltext

Verfügbarkeit prüfen

Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer

PloS one, 2013-08, Vol.8 (8), p.e71670-e71670

2013

Link zum Volltext

Verfügbarkeit prüfen

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers

PloS one, 2012-06, Vol.7 (6), p.e39167-e39167

2012

Link zum Volltext

Verfügbarkeit prüfen

SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers

Nature communications, 2017-01, Vol.8 (1), p.14098-13, Article 14098

2017

Link zum Volltext

Verfügbarkeit prüfen

Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines

PloS one, 2009-02, Vol.4 (2), p.e4576-e4576

2009

Link zum Volltext

Verfügbarkeit prüfen

Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability

PloS one, 2012-03, Vol.7 (3), p.e33003-e33003

2012

Link zum Volltext

Verfügbarkeit prüfen

Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling

Cancer research (Chicago, Ill.), 2015-02, Vol.75 (4), p.666-675

2015

Link zum Volltext

Verfügbarkeit prüfen

Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development

PloS one, 2012-05, Vol.7 (5), p.e37775

2012

Link zum Volltext

Verfügbarkeit prüfen

Dysregulation of fibulin-5 and matrix metalloproteases in epithelial ovarian cancer

Oncotarget, 2018-03, Vol.9 (18), p.14251-14267

2018

Link zum Volltext

Verfügbarkeit prüfen

Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor

PloS one, 2013-06, Vol.8 (6), p.e65624-e65624

2013

Link zum Volltext

Verfügbarkeit prüfen

SH3GL2 is frequently deleted in non-small cell lung cancer and downregulates tumor growth by modulating EGFR signaling

Journal of molecular medicine (Berlin, Germany), 2013-03, Vol.91 (3), p.381-393

2013

Link zum Volltext

Verfügbarkeit prüfen

Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma

Oncogene, 1999-01, Vol.18 (3), p.643-650

1999

Link zum Volltext

Verfügbarkeit prüfen

Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes

Translational lung cancer research, 2018-02, Vol.7 (1), p.32-49

2018

Link zum Volltext

Verfügbarkeit prüfen

Multifocal Lung Cancers—Clonality vs Field Cancerization and Does It Matter?

JNCI : Journal of the National Cancer Institute, 2009-04, Vol.101 (8), p.541-543

2009

Link zum Volltext

Verfügbarkeit prüfen

Consensus Coding Sequences of Human Breast and Colorectal Cancers

Science (American Association for the Advancement of Science), 2006-10, Vol.314 (5797), p.268-274

2006

Link zum Volltext

Verfügbarkeit prüfen

Molecular Pathogenesis of Malignant Mesothelioma and its Relationship to Simian Virus 40

Clinical lung cancer, 2003-11, Vol.5 (3), p.177-181

2003

Link zum Volltext

Verfügbarkeit prüfen

Multiple oncogenic changes (K-RASV12, p53 knockdown, Mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (4), p.2116-2128

2006

Link zum Volltext

Verfügbarkeit prüfen

Retraction notice to “Sun exposure related methylation in malignant and non-malignant skin lesions” [Cancer Letters 245/1-2 (2007) 112-120]

Cancer letters, 2018-09, Vol.432, p.272-272

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction: “From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers”

Journal of thoracic oncology, 2016-07, Vol.11 (7), p.e88-e89

2016

Link zum Volltext

Verfügbarkeit prüfen

Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study

Journal of clinical bioinformatics, 2011-09, Vol.1 (1), p.23-23

2011

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression

JNCI : Journal of the National Cancer Institute, 2001-05, Vol.93 (9), p.691-699

2001

Link zum Volltext

Verfügbarkeit prüfen

Abnormal expression of BRCA1 and BRCA1‐interactive DNA‐repair proteins in breast carcinomas

International journal of cancer, 2000-10, Vol.88 (1), p.28-36

2000

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-318: SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A-targeted therapies in non-small cell lung cancers (NSCLCs)

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.LB-318-LB-318

2016

Link zum Volltext

Verfügbarkeit prüfen

Retraction notice to “Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer” [Cancer Lett. 242 (2) (2006) 222–230]

Cancer letters, 2015-04, Vol.360 (1), p.87-87

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 246

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(230)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(78)
Biological And Medical Sciences
(41)
Medical Sciences
(35)
Tumors
(35)
Lung Cancer
(32)
Science & Technology
(27)
Female
(26)
Multidisciplinary Sciences
(26)
Science & Technology - Other Topics
(26)
Lung Neoplasms - Genetics
(23)
Lung Neoplasms - Pathology
(22)
Mutation
(20)
Oncology
(20)
Animals
(19)
Male
(19)
Cancer
(17)
Tumor Cells, Cultured
(17)
Middle Aged
(16)
Carcinoma, Non-Small-Cell Lung - Genetics
(14)
Cell Lines
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers

SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers

Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines

Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability

Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling

Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development

Dysregulation of fibulin-5 and matrix metalloproteases in epithelial ovarian cancer

Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor

SH3GL2 is frequently deleted in non-small cell lung cancer and downregulates tumor growth by modulating EGFR signaling

Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma

Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes

Multifocal Lung Cancers—Clonality vs Field Cancerization and Does It Matter?

Consensus Coding Sequences of Human Breast and Colorectal Cancers

Molecular Pathogenesis of Malignant Mesothelioma and its Relationship to Simian Virus 40

Multiple oncogenic changes (K-RASV12, p53 knockdown, Mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells

Retraction notice to “Sun exposure related methylation in malignant and non-malignant skin lesions” [Cancer Letters 245/1-2 (2007) 112-120]

Correction: “From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers”

Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study

Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression

Abnormal expression of BRCA1 and BRCA1‐interactive DNA‐repair proteins in breast carcinomas

Abstract LB-318: SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A-targeted therapies in non-small cell lung cancers (NSCLCs)

Retraction notice to “Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer” [Cancer Lett. 242 (2) (2006) 222–230]

Aktive Filter

Suchergebnisse filtern